Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 4-Bromo-3-methyl-5-phenyl-1,2-oxazole | HCID 12637255 | — |
| Reactant | 2,6-Dimethyl-8-(pentan-3-yl)imidazo[1,2-b]pyridazine | HCID 68841267 | — |
| Catalyst | HCID 178418476 | HCID 178418476 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 57932974 | HCID 57932974 | 23% |
Reaction Steps
Using the procedure analogous to Example 257, 8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine (200 mg, 0.90 mmol), 4-bromo-3-methyl-5-phenyl isoxazole (430 mg, 1.8 mmol), cesium carbonate (880 mg, 2.70 mmol) and PdCl2(PPh3)2 (25 mg) in DMF (5 ml) are combined and heated at 130° C. for 5 hrs to give the title compound (65 mg, 23% yield). ES-MS (m/z): calc'd for C23H26N4O: 374.5. found 375.1 (M+H)+. 1H NMR (400 mHz, CDCl3): δ 7.50 (d, 2H), 7.31 (m, 3H), 6.69 (s, 1H), 3.39 (m, 1H), 2.48 (s, 3H), 2.20 (s, 6H), 2.33 (s, 3H), 1.84 (m, 4H), 0.88 (m, 6H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07612067B2 |
|---|
| Source dataset | uspto-grants-2009_11 |
|---|
| ORD ID | ord-f909c311a49349d18cbeac6ca4d27be3 |
|---|
| Source note | uspto-grants-2009_11 |
|---|